Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Join | Sign in
Home>Products>Product News
  Service News
ERT Introduces GE Healthcare’s QT Guard Plus™ Analysis System
Friday, April 11, 2014
Novel approach may help to prevent false positive cardiac safety findings in new drug development.

Vetter Launches New Clinical Syringe Packages
Friday, April 11, 2014
Earlier syringe development may cut time-to-market, increase clinical trial appeal.

Immunovaccine's DepoVax™ Technology Underpins New Experimental Therapy for Cancers
Wednesday, April 09, 2014
IMV vaccine adjuvant technology of choice for Dana-Farber's HPV-related cancer clinical trial.

Epistem Announces Installation of UKs First Bruker Xtreme Imaging System
Tuesday, April 08, 2014
Xtreme system will enable Epistem to expand both the range and throughput of its imaging services.

Vetter to Implement Serialization to Support Track-and-Trace Efforts
Friday, March 28, 2014
Flexible service offering planned to go into effect in 2014.

BioOutsource Launches Flagship Reverse Signaling Apoptosis Bioassay
Tuesday, March 25, 2014
Presents webinar on improving speed to market for Biosimilars.

Kemwell Adds Lyophilization Capability
Saturday, March 22, 2014
Addition of the new freeze drying capability sets the Company on a course to expand business from both new and existing customers.

Catalent Launches ADVASEPT™ Advanced Aseptic Technology
Saturday, March 15, 2014
New technology for glass-free delivery of injectable drugs.

Lab Relocation Specialist Expands Turnkey Solution
Friday, March 07, 2014
Specialist laboratory relocation expert, Andrew Porter Limited, has further expanded its service portfolio.

<< 1 2 3 4 5 6 7 >>
Showing Results 21 - 30 of 298
Scientific News
NIH-supported Clinical Trials to Evaluate Long-acting, Injectable Antiretroviral Drugs
Both trials are expected to be completed in 2017.
Single-Cell, 42-plexed Protein Analysis Achieved with a New Microchip Technology
A novel microdevice capable of detecting 42 unique immune effector proteins has been developed.
Paramedics May be First Line of Treatment for Stroke
NIH study demonstrates feasibility of getting drugs to stroke patients faster.
Cancer Treatment with KU Origins Enters Second Clinical Trial
Cleave Biosciences has begun a Phase 1 clinical trial to evaluate CB-5083.
Ebola Vaccine Trial Opens in Liberia
Study led by Liberia-NIH partnership will test two experimental vaccines.
NIH Launches Tool to Advance Down Syndrome Research
Web portal will help approved professionals to plan clinical studies.
NIH Researchers Tackle Thorny Side of Gene Therapy
Pre-clinical studies in mice reveal ways to reduce cancer risk with modified treatment.
Early Blood Glucose Control Lengthens Life in People with Type 1 Diabetes
Reductions in diabetes complications resulting from tight glucose control translate into longer lifespans.
Oxford Vaccine Group Begins First Trial of New Ebola Vaccine
Oxford University doctors and scientists are starting the first safety trial of an experimental preventative Ebola vaccine regimen being developed by the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen).
GRP78 Protein Possible Universal Therapeutic Target
Drug combination including Viagra is effective tool in targeting the protein.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters